Eurodrug Laboratories

What Eurodrug Laboratories does

Eurodrug Laboratories is a Netherlands-headquartered specialty pharmaceutical company founded in 1984, operating from Den Haag with 51-100 employees. The company runs an in-licensing and out-licensing platform that sources European-developed pharmaceutical products and distributes them across emerging markets spanning 31 countries in Asia, Europe/CIS/MEA, and Latin America.

The company's product portfolio is organized across six therapeutic areas — Respiratory & Allergy, Gastroenterology & Metabolics, Paediatrics, Women's Health, Orthopedics & Pain, and others — supported by a full-stack service capability set covering Commercial Strategy, Logistics, Regulatory Affairs & Compliance, Pharmacovigilance, Medical Affairs, and Quality Assurance. This service infrastructure is positioned to onboard originator partners on the in-licensing side and to manage in-market distribution on the out-licensing side, with regional director presence in each of the three operating regions.

Revenue mechanics are characteristic of an asset-light licensing and distribution model: margins derive from the spread between originator acquisition cost and in-market distribution pricing, supplemented by licensing royalties. No financial disclosures, funding history, or named customer or partner relationships are publicly available, limiting visibility into revenue concentration and growth cadence. The company is privately held and led by CEO Eelco Broersma.

Name

Eurodrug Laboratories

Legal name

Eurodrug Laboratories

Website

https://eurodrug.nl

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

51–100 employees

Short description

Eurodrug Laboratories is a Netherlands-based specialty pharmaceutical company that in-licenses and out-licenses European-developed drugs across 31 emerging-market countries spanning Asia, Europe/CIS/MEA, and Latin America, covering six therapeutic areas.

Ownership category

akta.pro rank

Product category

Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)

akta.pro secondary industry

Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)

Keywords

• Pharmaceutical products
• Generic medicines
• Drug distribution
• Therapeutic solutions
• Pharma licensing

Headquarters

HQ city

Den Haag

HQ country

Netherlands

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Product Licensing - Out-licensing: Eurodrug helps pharmaceutical companies out-license their products into global markets through their proven network, end-to-end expertise, and local market knowledge, ensuring wider reach and sustainable growth.
2. Product Licensing - In-licensing: Eurodrug acquires licenses for European-developed medicines and distributes them across their global network in Asia, Europe, CIS, Middle East, Africa, and Latin America.
3. Pharmaceutical Product Sales: Sale of Eurodrug's portfolio of European-developed medicines across therapeutic areas including Respiratory, Gastroenterology, Pediatrics, Women's Health, Orthopedics & Pain.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Eurodrug Laboratories is a pharmaceutical company founded in 1984 and headquartered in Den Haag, Netherlands, that develops, manufactures, and distributes pharmaceutical products across six therapeutic categories. The firm offers six distinct service offerings to partners across Asia, Europe/CIS/MEA, and Latin America, generating revenue through product sales and licensing arrangements.

Product overview

Eurodrug Laboratories is a pharmaceutical company offering a portfolio of European-developed medicines across six therapeutic categories (Respiratory & Allergy, Gastroenterology & Metabolics, Paediatrics, Women's Health, Orthopedics & Pain, and Others). The product portfolio is complemented by six integrated service offerings: Commercial Strategy, Logistics, Regulatory Affairs & Compliance, Pharmacovigilance, Medical Affairs, and Quality Assurance. Together, these products and services form an end-to-end healthcare solution enabling out-licensing of pharmaceutical products into global growth markets including Asia, Europe, CIS, Middle East, Africa, and Latin America.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Product Portfolio - Therapeutic Category 1

Segments6 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• Local Healthcare PartnerscoreChannel Partner/ Reseller/ DistributorStrong local partnerships across Asia, Europe, CIS, Middle East, Africa, and Latin America to ensure timely, reliable healthcare delivery with on-ground presence and local market knowledge.
• In-License PartnerscoreStrategic or Co-development PartnerPartnerships with pharmaceutical companies to in-license European-developed medicines into Eurodrug's global distribution network, expanding product portfolio and market reach.
• Out-License PartnerscoreStrategic or Co-development PartnerEurodrug helps pharmaceutical companies out-license their products into global markets using proven network, end-to-end expertise, and local market knowledge — ensuring wider reach and sustainable growth.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• DKSH Holding: Swiss-listed market expansion services company providing healthcare distribution, regulatory, and marketing services across Asia — a direct comparability in B2B pharma distribution and licensing support for emerging markets.
• Eurofarma: Brazilian pharmaceutical company with a broad therapeutic portfolio and growing presence across Latin America, sharing Eurodrug's emerging-market distribution orientation and multi-therapeutic strategy.
• Cipla: Indian multinational with deep presence in respiratory, anti-retroviral, and other therapeutic categories, distributing across emerging markets including Africa and Asia — comparable therapeutic mix and emerging-market focus.
• Aspen Pharmacare: South African pharmaceutical company with a portfolio of branded and generic medicines distributed across emerging markets in Africa, Latin America, and Asia, operating a similar geographic thesis to Eurodrug.
• Julphar (Gulf Pharmaceutical Industries): UAE-based pharmaceutical manufacturer and distributor focused on the MENA region, with a similar product-portfolio-and-distribution model targeted at growth markets.
• Zuellig Pharma: One of the largest pharma distribution and services platforms in Asia, offering logistics, regulatory, and commercialization services — overlapping with Eurodrug's logistics and regulatory service offerings in growth markets.
• Hikma Pharmaceuticals: Jordanian-headquartered pharma company with strong MENA and emerging-markets presence across branded generics, injectables, and licensing — closely overlapping with Eurodrug's therapeutic breadth and distribution model.
• Acino: Swiss-headquartered pharmaceutical company focused on licensing, marketing, and distributing established medicines into emerging markets across the Middle East, Africa, CIS, and Latin America — the closest analog to Eurodrug's model.

Broad incumbents

• Sanofi: Global major pharmaceutical company with significant emerging-market operations and a portfolio spanning respiratory, gastroenterology, and other categories where Eurodrug operates, but at vastly larger scale and with proprietary R&D.
• Abbott Laboratories: Diversified global healthcare company with established pharma, diagnostics, and nutrition businesses, including branded generics distributed across emerging markets — overlapping categories but operating at incumbent scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eurodrug Laboratories